In convenience stores across Australia, sleek disposable vapes line the shelves in candy-bright colors with names like “Mango Tango” and “Strawberry Watermelon Ice.”
Among the most popular is IGET, a brand that dominates the Asia-Pacific market with devices capable of delivering up to 10,000 puffs—each one a carefully calculated dose of one of the world’s most addictive substances.
While marketed as a safer alternative to traditional cigarettes, new data reveals these devices are engineering a generation of nicotine addicts through a combination of high-tech delivery systems and brain chemistry manipulation that experts say rivals the addictive power of cocaine and heroin.
The Numbers Don’t Lie
Between 2019 and 2023, adult e-cigarette use in the United States surged from 4.5% to 6.5%, according to the CDC’s National Health Interview Survey. But it’s the youth statistics that paint the most alarming picture.
Among high school vapers, 39% now report using their devices 20 or more days per month—up from 34% in 2019. Most middle and high school students who vape want to quit, with 63.9% reporting this desire in 2020, and 67.4% having attempted to quit in the previous year.
The implications are staggering. Youth e-cigarette use has increased by 1,800% in recent years, with disposable vapes like IGET becoming the delivery method of choice. In Minnesota alone, one in four 11th graders now use e-cigarettes, up from 17.1% in 2016—a 54% increase.
Inside the Addiction Machine
IGET vapes don’t use traditional freebase nicotine—they’ve upgraded to something far more insidious: nicotine salts. Think of freebase nicotine as the rough draft and nicotine salts as the perfected formula specifically designed to slide past your throat’s natural defenses.
In a cross-sectional study of e-cigarette users in England, 16.7% reported feeling very addicted to e-cigarettes, while 42.3% considered e-cigarettes equally or more addictive than tobacco cigarettes. The data shows this isn’t perception—it’s chemistry.
A typical IGET device contains 50mg/mL of nicotine salt, roughly equivalent to an entire pack of cigarettes compressed into a single disposable unit.
The nicotine salts allow manufacturers to pack in concentrations that would be unbearably harsh in traditional cigarette form, but go down smooth in vapor form.
The speed matters. Research demonstrates that nicotine salts hit the bloodstream faster than combustible cigarettes, triggering an immediate dopamine release in the brain’s reward center.
It’s the same neural pathway activated by cocaine, heroin, and methamphetamine—substances we universally recognise as highly addictive.
The Withdrawal Trap
Try to quit, and your body makes its displeasure brutally clear. Withdrawal symptoms peak on the second or third day of being nicotine-free, with symptoms fading over three to four weeks.
But the timeline tells only part of the story. Cravings can begin within an hour or two after last use, occurring frequently for the first few days or weeks, though occasional mild cravings can persist months or years after quitting.
The symptoms themselves read like a greatest hits of human misery: crushing anxiety, irritability that makes you unrecognisable to yourself, difficulty concentrating that turns simple tasks into Herculean efforts, disrupted sleep, headaches, and depressed mood.
Most symptoms of vaping withdrawal return to baseline levels within 10 days of quitting, research suggests.
But those 10 days represent an eternity when you’re trapped in the grip of nicotine withdrawal. It’s why relapse rates remain so high, with most occurring within the first two weeks of attempting to quit.
The Convenience Factor Compounds the Crisis
Here’s where devices like IGET become especially dangerous. A cigarette has a natural stopping point—you finish it, you’re done. Disposable vapes eliminate that boundary entirely.
Users report taking hits while scrolling social media, during work breaks, in bathrooms, even in bed.
The lack of visible smoke, minimal odor, and pocket-sized portability mean these devices can be used virtually anywhere, at any time. Behavioural researchers call this “grazing behaviour”—small, frequent puffs throughout the day that users often don’t consciously register.
This constant availability creates powerful conditioned responses. Your brain begins pairing the nicotine hit with dozens of daily moments: morning coffee, stress at work, boredom in line, social gatherings.
Students reported that the top ways they obtained e-cigarettes included getting products from friends (72.3%), vape shops (14.0%), and the Internet (9.6%).
The ease of access, combined with flavors that mask the drug delivery—everything from bubble gum to pomegranate cherry ice—creates what public health officials describe as a perfect storm for addiction.
The Developing Brain Crisis
If you’re under 25, the stakes are exponentially higher. The prefrontal cortex, responsible for decision-making and impulse control, doesn’t fully mature until around age 25. Introducing nicotine during this critical development period fundamentally alters brain architecture.
Electronic cigarettes typically contain nicotine, which is addictive and can harm brain development through about age 25. The damage isn’t theoretical—it’s measurable in clinical studies showing changes in attention, learning capacity, mood regulation, and impulse control.
Nicotine can harm the parts of an adolescent’s brain that control attention, learning, mood, and impulse control. Worse, early nicotine exposure primes the brain for future substance dependencies. The World Health Organisation states that children who vape are more than twice as likely to start smoking.
Market Forces Drive the Machine
The global e-cigarette market tells its own story. Valued at $28.17 billion in 2023, projections show it reaching $182.84 billion by 2030—a compound annual growth rate of 30.6%. In the United States alone, the market expanded from $8.98 billion in 2022 and continues its aggressive climb.
IGET has positioned itself strategically in this gold rush. Headquartered in Australia and widely popular across the Asia-Pacific region, the brand offers devices ranging from 2,600 to over 12,000 puffs.
The 2024 line features mesh coil technology, which provides faster activation and more consistent nicotine distribution throughout the device’s lifespan.
In the U.S. market, brands like Vuse captured 38.5% of market share in 2023, with JUUL taking 28%. But the real story is in disposables—the segment that’s exploding in popularity precisely because of how seamlessly it delivers addiction.
Brands like GEEK BAR PULSE, BREEZE SMOKE, and RAZ have surged into the top 10, each optimised for ease of use and maximum nicotine delivery.
The Regulatory Gap
Here’s the uncomfortable truth: thousands of flavored, high-nicotine products remain on the market, many illegally. While the FDA has attempted regulatory oversight, enforcement remains sporadic at best.
76.1% of 11th graders said there is either no, slight, or moderate risk to using e-cigarettes. This massive gap between perception and reality isn’t accidental—it’s the result of aggressive marketing that has positioned vaping as harmless, fun, and socially acceptable.
In 2021, more than 75% of middle and high school students reported exposure to marketing or advertising of any nicotine or tobacco product—including e-cigarettes.
The campaigns operate across social media, retail environments, and even through influencer partnerships that deliberately obscure the addictive nature of the products.
What the Science Shows
The research is unambiguous. Brain imaging studies demonstrate that nicotine users show the same patterns of neural activation as people dependent on cocaine or heroin.
The dopamine receptor changes, the withdrawal syndrome, the compulsive use despite known harm—these are hallmarks of addiction, not casual habit.
Both vape pens and tobacco products come with health consequences. Many vaping products contain nicotine, which can cause fetal developmental problems during pregnancy. E-cigarette vapour also has substances that may cause lung disease, cancer-causing chemicals, and heavy metals.
The toll isn’t just neurological. As of February 2020, EVALI (e-cigarette or vaping product use-associated lung injury) had caused 68 deaths across 29 states and the District of Columbia.
The long-term health effects remain under study, but early indicators suggest significant cardiovascular and respiratory impacts.
The Testosterone Crisis No One’s Talking About
While much of the public conversation around vaping focuses on lung health and addiction, emerging research reveals a disturbing impact on male hormones that manufacturers aren’t advertising on their mango-flavored packaging.
Animal studies reveal alarming hormonal disruption. Research on rats exposed to e-cigarette vapor—both with and without nicotine—showed testosterone levels plummeting by 30% to 50%.
The studies identified decreased expression of key enzymes responsible for testosterone production: cytochrome P450scc and 17β-Hydroxysteroid dehydrogenases.
Men who regularly use vaping devices for an hour or more daily may experience testosterone decreases of approximately 30% compared to non-vapers, according to recent endocrine research. This isn’t a minor fluctuation—it’s a hormonal shift with cascading effects throughout the body.
A 2022 Swedish study of 613 men found oral tobacco users had 24% lower sperm counts than non-users, though paradoxically showed 14% higher testosterone levels.
Particularly disturbing: nicotine-free e-liquids also appear to disrupt hormones. This suggests the chemicals in the vaping liquid itself, including propylene glycol and vegetable glycerin, act as endocrine disruptors regardless of nicotine content.
The implications extend beyond the gym. Lower testosterone levels are associated with decreased muscle mass, increased body fat, reduced energy levels, mood changes including depression and irritability, and decreased libido.
For younger men—the primary demographic picking up IGET vapes—these hormonal changes can affect everything from athletic performance to mental health to sexual function.
The long-term reversibility remains uncertain. Researchers don’t yet know whether stopping vaping reverses testosterone suppression or if the damage becomes permanent.
Some animal studies showed recovery of testosterone levels after nicotine cessation, suggesting potential reversibility—but human studies remain limited.
What’s certain is that the 23.1% of e-cigarette users who never smoked traditional cigarettes—most of them younger than 35—are developing hormonal problems they likely never anticipated when they picked up their first fruit-flavored vape.
Breaking Free Is Possible—But Difficult
Understanding the mechanisms behind vaping addiction doesn’t make you weak. It makes you informed. Your brain is doing exactly what evolution designed it to do: seeking rewards and avoiding discomfort. IGET vapes and similar devices have simply hacked that system with terrifying efficiency.
For those attempting to quit, the statistics offer both hope and warning. Symptoms will get better every day, especially after the third day following stopping. Nicotine replacement therapy, behavioral counseling, and support systems all improve success rates.
But make no mistake—this is a battle against biology and a multi-billion-dollar industry that profits from dependency. The first two weeks remain critical, when most relapses occur. The physical symptoms eventually fade, but psychological cravings can persist far longer.
The question facing public health officials, regulators, and users themselves is stark: How many more people need to become addicted before we acknowledge that these devices aren’t harm reduction tools—they’re precision-engineered addiction delivery systems wrapped in appealing flavors and sleek packaging?
The data is clear. The science is settled. What remains to be seen is whether policy and public awareness can catch up to the crisis already unfolding in schools, homes, and communities across the globe.
